Memorial Sloan Kettering Psychopharmacology in Cancer Care: An Update for Clinicians of All Disciplines
Saturday, March 2, 2019 - Saturday, March 2, 2019
CME Provider:
Memorial Sloan Kettering Cancer Center › MSK CME 633 3rd Ave, 12th Floor New York, New York (NY) 10017 United States
Phone: 646-227-2025
Visit the CME Provider Webpage ›
Conference Center:
Rockefeller Research Laboratories › 430 E 67th Street New York, New York (NY) 10065 United States
Phone: 800-525-2225
Visit the Conference Center Webpage ›
Description:
Clinicians have numerous tools at their disposal to help adult cancer patients dealing with symptoms of depression, anxiety, and other cancer sequelae. Psychiatric medications are most frequently prescribed to cancer patients by oncologists and general practitioners, however psychiatric syndromes are often underdiagnosed and undertreated. Few oncology practices have dedicated psychiatric consultants familiar with the nuances of Psycho-Oncology. Even when patients receive psychotropic medications appropriately, they may have problems that arise before their next oncology visit or before they see the person who prescribed their psychiatric medications. Psychologists, nurses and social workers play an essential role in identifying psychological and physical symptoms as well as both beneficial and problematic medication effects as they provide frontline psychosocial interventions and support for cancer patients.
This course is designed for the non-prescribing psycho-oncology clinician as well as the psychiatrist who is new to the world of Psycho-pharmaco-oncology. Oncologists, palliative care clinicians, advanced practice nurses and oncology nurses will find this course useful as well. The course will focus on key target disorders and symptoms amenable to psychopharmacological intervention, including anxiety, depression, delirium, insomnia, pain, fatigue and cachexia. Participants will learn to identify psychological reactions to medical conditions or treatments; psychiatric presentations of medical conditions or treatments; medical presentations of psychiatric conditions and common medical complications of psychiatric conditions or treatments.
Basic information will be presented about medications used to alleviate Quality of Life symptoms that arise in the cancer setting from diagnosis to survivorship or end of life care, and the interface of psychotherapy and medication management. We will review why certain medications are used and why some are avoided, looking at potential benefits, unwanted side effects, and drug-drug interactions, since you may be the first person to identify a serious adverse event. The course will also enhance your ability to provide psychoeducation to patients regarding psychiatric medications.
This course is co-sponsored by the MSK Psycho-Oncology Education & Training Institute (POETI).
Visit the CME Course Webpage › View the Course Brochure ›
Instructors:
MSK Course Faculty:
Andrew Roth, MD William Breitbart, MD Yesne Alici, MD
Special Guest Faculty:
Nessa Coyle, PhD, RN, FAAN
CME Credit:
Physicians: 6.50 Hours
Nurses: 6.50 Hours
Self Assessment Module (SAM):
No
Specialty Audience:
Family Medicine Internal Medicine Practice Management Preventative Medicine Psychiatry
RADLIST Course #19653
|
Map of
Rockefeller Research Laboratories, 430 E 67th Street, New York, New York (NY), United States
|
|
Show Nearby:
Rank By:
|
|
|
|
|
|